John W. Kozarich, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 2,501 shares at $227.37 ($563K) on 2026-05-01, disclosed to the SEC on 2026-05-14.
Scheduled sale ($563k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $227.37 | 80 | $18K | 3.2% |
| 2 | $229.87 | 1 | $230 | 0.0% |
| 3 | $231.87 | 165 | $38K | 6.8% |
| 4 | $232.57 | 105 | $24K | 4.3% |
| 5 | $234.09 | 116 | $27K | 4.8% |
| 6 | $224.00 | 459 |
| $103K |
| 18.3% |
| 7 | $223.50 | 1,575 | $352K | 62.5% |
| Total | $225.14 avg | 2,501 | $563K | 100% |
| Filing → |
| LGND | SELL | 2026-02-04 | $175K | — | Filing → |
| LGND | SELL | 2026-01-06 | $173K | — | Filing → |
| LGND | SELL | 2025-12-03 | $91K | — | Filing → |